Joshua Silverman My Md Pharmaceuticals, Inc. (MYMD) insider trading activity

Joshua Silverman is Executive Chairman of MyMD Pharmaceuticals, Inc.. Currently has a direct ownership of 100,029 shares of MYMD, which is worth approximately $171,049. The most recent transaction as insider was on Nov 14, 2025, when has been sold 91,356 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

1053.34% 3M change

12.68% 12M change

Total Value Held $171,049

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2025	BUY Grant, award, or other acquisition	-	91,356 Added 47.73%	100,029 Common Stock
Oct 03 2025	BUY Grant, award, or other acquisition	-	8,644 Added 49.92%	8,673 Common Stock
Nov 26 2021	BUY Open market or private purchase	$37,750 $7.55 p/Share	5,000 Added 5.33%	88,775 Common Stock
Nov 24 2021	BUY Open market or private purchase	$67,000 $6.7 p/Share	10,000 Added 10.66%	83,775 Common Stock
Apr 16 2021	SELL Payment of exercise price or tax liability	$189,326 $4.94 p/Share	38,325 Reduced 35.0%	71,175 Common Stock
Apr 16 2021	BUY Exercise of conversion of derivative security	-	109,500 Added 49.41%	112,101 Common Stock

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Chief Executive Officer

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

SNPX

Synaptogenix, Inc. Healthcare

Executive Chairman

FEMY

FEMASYS INC Healthcare

PMCB

PharmaCyte Biotech, Inc. Healthcare

CEO and President